Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 17;annrheumdis-2020-217018.
doi: 10.1136/annrheumdis-2020-217018. Online ahead of print.

Rheumatic Disorders Associated With Immune Checkpoint Inhibitors: What About Myositis? An Analysis of the WHO's Adverse Drug Reactions Database

Affiliations

Rheumatic Disorders Associated With Immune Checkpoint Inhibitors: What About Myositis? An Analysis of the WHO's Adverse Drug Reactions Database

Thủy Nguyễn et al. Ann Rheum Dis. .

Abstract

No abstract available

Keywords: autoimmune diseases; dermatomyositis; epidemiology; polymyositis.

Conflict of interest statement

Competing interests: ATJM has received fees from Abbvie, Actelion, CSL Behring, Experf, Novartis and Shire, and declares speaking fees from Astra-Zeneca and BMS in the last 5 years. PG is a medical expert for LFB (Laboratoire Français du Biofractionnement) and has received fees from Abbvie, Actelion, Boehringer Ingelheim France, Bouchara-Recordati, Novartis, Pfizer and Roche in the last 5 years. OL has received expert testimony and consultancy fees from BMS France, MSD, Astra Zeneca; consultancy fees from Genzyme, Incyte, and expert testimony for Janssen. Other authors declare that they have no conflicts of interest.

Similar articles

See all similar articles

LinkOut - more resources

Feedback